BA – Southern Illinois University, Carbondale, Illinois
MD – St. Louis University School of Medicine, St. Louis, Missouri
- Hematopoietic cell transplant for high risk leukemia
- Use of alternative donors in patients lacking a fully matched sibling donor
- Immune reconstitution following hematopoietic cell transplant
- Broadening the use of hematopoietic cell transplant for patients with non-malignant diseases
Leung W, Yang J, Campana D, Pei D, Gan K, Rubnitz JE, Sandlund JT, Ribeiro RC, Srinivasan A, Hartford C, Triplett BM, Dallas M, Pillai A, Pui C-H. High success rate of hematopoietic cell transplantation regardless of donor source in children with very-high-risk leukemia. Blood 2012 (in press).
Triplett B, Horwitz EM, Iyengar R, Turner V, Holladay M, Gan K, Behm FG, Leung W. Effects of Activating NK Cell Receptor Expression and NK Cell Reconstitution on the Outcomes of Unrelated Donor Hematopoietic Cell Transplantation for Hematologic Malignancies. Leukemia 2009 (in press).
Triplett B, Handgretinger R, Pui CH, Leung W. KIR-incompatible hematopoietic-cell transplantation for poor prognosis infant acute lymphoblastic leukemia. Blood 107(3):1238-9, 2006.
Leung W, Iyengar R, Triplett B, Turner V, Behm FG, Holladay MS, Houston J, Handgretinger R. Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors. J Immunol 174(10):6540-5, 2005.
Last update: March 2012